← All indications
Intervertebral Disc Degeneration
Degenerative changes in the INTERVERTEBRAL DISC due to aging or structural damage, especially to the vertebral end-plates.
Drugs by status
Phase 3 trials (12)
Phase 2 trials (23)
- allostim
- autologous bone graft
- abaloparatide
- bone allograft
- bone marrow derived mesenchymal stem cells
- ketorolac
- recombinant human gdf-5
- mepivacaine
- pamidronate
- propranolol
- teriparatide
- yh14618
- allogeneic adipose derived mesenchymal stem cell
- allogeneic osteoblastic cells
- autologous culture chondrocytes
- neofuse
- autologous mesenchymal stem cells
- tranexamic acid
- water
- discogenic cells
- allogeneic mesenchymal stem cells
- cordstem-dd
- Adult Neural Progenitor Cells
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (24)
- Spinal Restoration, Inc.
- Campus Bio-Medico University
- Institut de Terapia Regenerativa Tissular
- New York University
- University of Minnesota
- University of Montpellier
- Rush University
- University of Lyon
- Citospin
- Mesoblast, Inc.
- University of Valladolid
- University of Nantes
- University of Paris
- European Clinical Research Infrastructure Network
- University of Rennes
- National University of Ireland
- IQVIA
- R3 Stem Cell
- University of Navarra
- Interdisziplinäres Zentrum Klinische Studien (IZKS)
- BG Klinikum Bergmannstrost, Halle, Germany
- Univercell-Biosolutions S.A.S
- Stem Cures
- Pauza, Kevin, MD
Organization Involved with Phase 2 Indications (30)
- ISTO Technologies, Inc.
- Red de Terapia Celular
- Bone Therapeutics S.A
- Kuros Biosurgery AG
- Tetec AG
- Duke University
- Johns Hopkins University
- Medical University Innsbruck
- Northwestern University
- University of Iowa
- Virginia Commonwealth University
- Kangbuk Samsung Hospital
- University of Indonesia
- Carolina Neurosurgery and Spine Associates
- Janssen Pharmaceutica NV
- University of Halle
- Drug Studies America
- Texas Back Institute
- Durango Orthopedic Associates/Spine Colorado
- Riverhills Healthcare, Inc.
- DePuy
- Foundation for Anesthesia Education and Research
- Yuhan Pharmaceutical Company
- Johnson and Johnson
- University Clermont Auvergne
- DiscGenics, Inc.
- Factory CRO
- University Hospital Motol, Prague, Czech Republilc
- Bioinova, s.r.o.
- BioRestorative Therapies
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (6)